ASCO 2025 – Final Day Highlights in Breast Cancer with Dr. Kim Ma

Dr. Kim Ma highlights key data from the final day of ASCO 2025 on localized breast cancer, exploring emerging themes in neoadjuvant HER2 therapy, lymph node management in surgery, and the evolving role of ovarian suppression.